Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Towards Ending HCV Infection Among Active Drug Users: a Community-based Intervention in Montpellier.

NCT04008927 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.

NCT NCT04008927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04008927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Towards Ending HCV Infection Among Active Drug Users: a Community-based Intervention in Montpellier.
Lead sponsor
ANRS, Emerging Infectious Diseases
Phase
Not applicable
Overall status
Completed
Start date
September 18, 2020
Completion date
September 10, 2021
Enrollment
554 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug use, hcv infection